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ABSTRACT
Next-generation DNA sequencing technology was
used to score >100000 mutations resulting from
exposure of a nucleic acid template to a mutagenic
dNTP analog during a single pass of a DNA poly-
merase. An RNA template of known secondary
structure was reverse transcribed in the presence
of 8-oxo-dGTP, dPTP or both, followed by forward
transcription in the presence of standard NTPs.
Each mutagen, whether used alone or in combin-
ation, resulted in a highly characteristic mutation
profile. Mutations were generated at a mean fre-
quency of 1–2% per eligible nucleotide position,
but there was substantial variation in the frequency
of mutation at different positions, with a SD close to
the mean. This variation was partly due to the
identity of the immediately surrounding nucleotides
and was not significantly influenced by the second-
ary structure of the RNA template. Most of the
variation appears to result from idiosyncratic
features that derive from local sequence context,
demonstrating how different genetic sequences
have different chemical phenotypes.
INTRODUCTION
Genetic mutations can have deleterious effects in the short
term, but also provide the basis for evolutionary innova-
tion, and thus are critical to understanding heritable
disease, cancer progression and the development of
novel biological traits. The frequency of mutations can
be increased by various mutagens, each mutagen resulting
in a characteristic spectrum of genetic changes. One of the
most common cellular mutagens is 8-oxo-dG, which
results from oxidative damage to DNA and increases the
frequency of G-to-T mutations due to its ability to
pair with either C or A residues (1–3) (Figure 1A).
Another potent mutagen is the synthetic compound dP,
containing the bicyclic pyrimidine analog 3,4-dihydro-
8H-pyrimido-[4,5-C][1,2]oxazin-7-one (4). This compound
can pair with either G or A residues, and thus promotes
C-to-T mutations (5,6) (Figure 1B). In the laboratory,
mutagens such as these are employed to study the mech-
anisms of genetic alteration and to construct populations
of variants that can be culled for individuals possessing
desired phenotypic characteristics.
The usual approach for measuring the frequency of mu-
tations that result from exposure to a particular mutagen
is to score a phenotypic change that derives from a speciﬁc
genetic polymorphism. Several different sites of poly-
morphism can be interrogated to evaluate how the
mutation proﬁle differs in different sequence contexts.
Any phenotypic assay is indirect and potentially affected
by selection bias, although one can couple the phenotypic
assay with DNA sequencing to conﬁrm the presence or
absence of the indicated mutations. With the advent of
‘next generation’ sequencing technologies, it should
be possible to avoid phenotypic scoring and simply
sequence large numbers of DNA molecules that have
been exposed to a mutagen. Even then, one must guard
against potential selection bias that can arise whenever
different DNA sequences are co-ampliﬁed.
Ideally one would expose a sample nucleic acid to a
mutagen, then sequence large numbers of individual mol-
ecules without performing ampliﬁcation. For mutagens
that are provided as a dNTP analog a minimum of two
passes of a polymerase are required: one to incorporate
the analog into DNA, and the other to copy the poten-
tially modiﬁed DNA to bring about either mutation or
reversion. Until single-molecule sequencing technologies
become available, further ampliﬁcation is required,
which should be carried out in the absence of the
mutagen and with minimal selective bias.
The present study involved reverse transcription of an
RNA template in the presence of either 8-oxo-dGTP or
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absence of a mutagen, then high-ﬁdelity PCR ampliﬁca-
tion and the sequencing of millions of DNA molecules.
Control reactions, carried out in the absence of a
mutagen, were processed in a side-by-side manner to
assess the basal mutation rate and potential sequencing
errors. The template RNA contained 126 nucleotide pos-
itions that were potentially mutable, and the sequencing
coverage averaged >40 000 reads per position. Thus it was
possible to obtain a precise estimate of the frequency of
mutation at each position and to survey enough positions
to determine the effects of sequence context.
Reaction conditions were chosen that sought to
maximize incorporation of the mutagen without
compromising the efﬁciency of polymerization. Under
these conditions it was possible with 8-oxo-dGTP to
generate A-to-C changes (referring to the starting
compared to product RNA) at a frequency of 1.2% per
eligible position; and with dPTP to generate A-to-G and
G-to-A changes at a frequency of 1.7 and 1.6% per eligible
position, respectively. When the two mutagens were
combined, their effects were additive. The frequency of
mutations at non-eligible positions was <0.1% overall,
and did not differ signiﬁcantly compared to that for
control samples that had not been exposed to a mutagen.
Surprisingly, there was a high degree of variation in the
frequency of mutagen-induced changes for different
eligible positions, with an SD close to the mean. Some
of this variation could be attributed to nearest-neighbor
effects, but most appears to be idiosyncratic with regard
to local sequence context. Compositional biases and the
secondary structure of the starting template nucleic acid
do not play a signiﬁcant role. Rather it appears that dif-
ferent genetic sequences have different chemical pheno-
types that reﬂect both the intrinsic properties of the
nucleic acid molecule and the way those properties
are expressed within the environment of a polymerase
active site.
MATERIALS AND METHODS
Mutagenesis procedure
Catalytic RNA having the sequence 50-AGAAGAAAGA
AAUUUCUCUAAUAGUGAUCCUUGUGAUUUGU
GUGAUCUCAAUCCUAAGACUGAACGUUAUGG
AUCAAUGGGUAGGUUCCAAGUAGAGCAGACG
AUAAAGUGUUUCCGUUCCCUAGUAGAUUGCG
AGUCGUAUUUUGACGUGGCUGACUCCGUGCC
AUCC-30 was prepared by in vitro transcription of the
corresponding DNA template (primer binding sites
underlined), then puriﬁed by denaturing polyacrylamide
gel electrophoresis (PAGE). The RNA was allowed to
react with a chimeric DNA-RNA substrate having the
sequence 50-CATCGTGCCTTGCTGCTCTAATACGA
CTCACUAUU-30 (T7 promoter sequence underlined;
RNA residues in bold), resulting in ligation of the sub-
strate to the 50-end of the catalytic RNA. The reaction
mixture contained 2mM catalytic RNA, 10mM substrate,
15mM MgCl2, 50mM KCl and 50mM EPPS (pH 8.5),
which was incubated at 37 C for 1h. The ligated RNA
was again puriﬁed by PAGE.
Of the ligated RNA, 30 pmols were used to initiate
reverse transcription and subsequent forward transcrip-
tion in a common reaction mixture containing 0.5mM
RNA and 2.5mM cDNA primer having the sequence
50-T23XXXGGATGGCACGGAGTCAG-30, where X
corresponds to an abasic DNA spacer (Glen Research).
The abasic spacer causes transcription to terminate at a
position corresponding to the starting RNA molecule, and
the oligo(T) tail provides size discrimination between the
cDNA and newly-transcribed RNA. The reaction mixture
also contained 4.5U/ml RNAse H–MMLV reverse tran-
scriptase, 2.5U/ml T7 RNA polymerase, 0.001U/ml inor-
ganic pyrophosphatase, various formulations of dNTPs,
2mM each NTP, MgCl2 at a concentration of 14.2mM
plus the total concentration of dNTPs, 50mM KCl, 4mM
DTT and 50mM EPPS (pH 8.5), which was incubated at
37 C for 1h. The newly transcribed RNAs were puriﬁed
Figure 1. Alternative pairing of mutagenic base analogs. (A) 8-oxo-G can pair with either C or A; (B) P can pair with either G or A.
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Sequencing and data analysis
Of the mutagenized RNA, 10 pmols were reverse
transcribed in a reaction mixture containing
0.5mM RNA, 2.5mM cDNA primer having the sequence
50-GGATGGCACGGAGTCAG-30, 4.5U/ml RNAse
H–MMLV reverse transcriptase, 0.5mM each dNTP,
3mM MgCl2, 75mM KCl, 10mM DTT and 50mM Tris
(pH 8.3), which was incubated at 37 C for 1h. The RNA
then was digested using 5U RNase H and 2U
RiboShredder (Epicentre Biotechnologies), incubating at
37 C for 20min. The remaining cDNA then was PCR
ampliﬁed using high-ﬁdelity PfuUltra polymerase
(Stratagene), employing the same primer as above and a
forward primer having the sequence 50-AGAAGAAAGA
AATTTCTCTAATAGTG-30. Of the PCR products, 5
pmols were fragmented in a 20-ml reaction mixture con-
taining 10
 4U/ml DNase I, which was incubated at 37 C
for 20min. Fragments of 55–105bp were size-selected in a
2% agarose gel and puriﬁed using the Zymo gel extraction
kit (Zymo Research). The fragments were end repaired,
tailed with deoxyadenosine, and ligated to Illumina-
compatible adaptors containing 6-nt barcodes having the
sequence: 50-CAACCT-30 for the control library; 50-TAC
GTT-30 for the 8-oxo-dGTP library; 50-AACCAT-30 for
the dPTP library and 50-GACTGT-30 for the combined
8-oxo-dGTP/dPTP library. Ligated products containing
120–200bp were puriﬁed by 2% agarose gel electrophor-
esis, PCR ampliﬁed to enrich fragments containing both
adaptors, and again gel puriﬁed, selecting molecules con-
taining 150–210bp.
The four barcoded libraries were pooled and used for
cluster generation in a single multiplexed ﬂow cell lane in
the Illumina Gene Analyzer IIx system. Single-read
sequencing by synthesis (80 cycles) was performed,
running phi X 174 genomic DNA as a control in a
separate lane of the ﬂow cell. The Illumina Genome
Analyzer Pipeline Software (version 1.4.0) was used to
carry out image analysis, base calling and quality score
calibration. Reads were sorted by barcode and exported
in the FASTQ format.
Subsequent data processing was performed using the
high-throughput sequencing module of CLC Genomics
Workbench (version 3.6; CLC bio). One million sequences
were imported for each library. Trimming was done to
remove adaptor sequences and ambiguously read nucleo-
tides. Trimmed reads <20nt were discarded and the re-
maining reads were aligned relative to the reference
sequence. The default local alignment settings for long
reads were used to rank all potential matches, with
mismatch cost=2, deletion cost=3 and insertion cost
=3. The highest scoring matches that shared  80%
identity with the reference sequence across  50% of
their length were included in the alignment. This permis-
sive alignment ensured that reads derived from highly
mutated molecules would not be discarded.
The SNP detection application in CLC Genomics
Workbench was used to evaluate variants that differed
compared to the reference sequence. This software uses
a modiﬁed version of the neighborhood quality standard
(7,8) to determine which reads at a given position should
be included in the analysis. For inclusion, a position must
meet a minimum quality score, must be in the center of an
11-nt window with no more than two gaps and/or
mismatches compared to the reference sequence, and
must be accompanied by surrounding nucleotides in the
window that also meet a minimum quality score. Either
increasing the maximum number of gaps/mismatches or
decreasing the window length did not signiﬁcantly alter
the calculated mutation frequency. Various minimum
quality scores were tested to evaluate sensitivity to this
variable.
RESULTS
Mutagenesis with dNTP analogs
A well-characterized RNA molecule, with known second-
ary structure, was chosen as the starting template for in-
corporation of mutagenic dNTP analogs. This RNA is the
DSL ribozyme, which catalyzes ligation of an oligonucleo-
tide substrate to the 50-end of the ribozyme (9). If the
substrate has the sequence of an RNA polymerase
promoter element, then the ribozyme can be made to
undergo repeated rounds of ligation and selective ampliﬁ-
cation at a constant temperature within a single reaction
mixture (10). Each round of ampliﬁcation involves reverse
transcription to generate promoter-containing cDNA
followed by forward transcription to generate new
copies of the RNA. If the substrate for RNA-catalyzed
RNA ligation is present in the mixture, then the
newly-synthesized RNA also can react and initiate
further ampliﬁcation. If, however, one begins with
reacted RNA and does not provide substrate, then the
ampliﬁcation process is limited to a single round of
reverse and forward transcription. Such a condition was
employed to allow one pass to incorporate the dNTP
analog followed by one pass to copy the incorporated
analog and bring about mutation.
Preliminary experiments were carried out to determine
the maximum concentration of 8-oxo-dGTP or dPTP (or
both) that could be included in the reaction mixture
without compromising the efﬁciency of polymerization.
The concentrations of the competing dNTPs were
reduced as tolerated to maximize the frequency of muta-
tions brought about by the dNTP analogs. For
8-oxo-dGTP, which can pair with either C or A, the con-
centrations of dGTP and TTP were reduced and for
dPTP, which can pair with either G or A, the concentra-
tions of dCTP and TTP were reduced. Compared to the
standard condition for reverse transcription, which
employed 0.2mM of each dNTP, the condition for
8-oxo-dGTP mutagenesis employed 8mM 8-oxo-dGTP,
0.05mM dGTP and 0.075mM TTP; the condition for
dPTP mutagenesis employed 0.25mM dPTP, 0.075mM
dCTP and 0.075mM TTP and the condition for
combined 8-oxo-dGTP/dPTP mutagenesis employed
8mM 8-oxo-dGTP, 0.25mM dPTP, 0.05mM dGTP,
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centrations remained 0.2mM).
Employing the formulations described, as well as
standard dNTP concentrations as a control, the starting
RNA was reverse transcribed using RNAse H–MMLV
reverse transcriptase, then forward transcribed using T7
RNA polymerase in the presence of the four standard
NTPs. This allowed incorporation of 8-oxo-dGTP
opposite C or A positions of the starting RNA, which in
turn could be read out as either C or A in the product
RNA. Similarly the incorporation of dPTP could occur
opposite G or A positions of the starting RNA and
could be read out as either G or A. The product RNA,
which is smaller in size compared to both the starting
RNA and the cDNA, was puriﬁed by high-resolution
PAGE, then reverse transcribed in the presence of
standard dNTPs. This provided mutagen-free DNA that
was used for sequence analysis. The RNA was degraded
using ribonuclease (avoiding alkali which could promote
deamination of dC to dU), then the cDNA was PCR
ampliﬁed using a high-ﬁdelity DNA polymerase. The
PCR products were fragmented, size selected, and
prepared for sequencing on the Illumina platform.
Adapters with distinct barcode sequences were attached
to the four different sets of material so that sequencing
could be carried out in a multiplex fashion within a single
lane of the ﬂow cell of the Illumina instrument.
The starting amount of RNA was 30 pmols, the amount
of mutagenized RNA used for RT-PCR was 10 pmols and
the amount of PCR DNA used for sequencing was 5
pmols. Following attachment of the adapters, additional
PCR ampliﬁcation was carried out to enrich molecules
that contained adapters at both ends. Subsequent ampli-
ﬁcation occurred clonally within the ﬂow cell of the se-
quencer. Approximately 10
 5 pmols of DNA were
clonally ampliﬁed and sequenced, which is a sparse
sampling of the input material, ensuring that individual
sequence reads were unlikely to be related by descent.
Each of the steps of DNA ampliﬁcation, although
carried out with a high-ﬁdelity polymerase and using
standard dNTPs, provided an opportunity for additional
mutagenesis due to polymerase error. In addition, the
standard dNTPs inevitably contain a small amount of
modiﬁed bases that could promote mutations. Even the
synthetic DNA primers may contain chemical lesions that
could give rise to mutations in portions of the DNA that
were not exposed to the dNTP analogs. Thus the standard
dNTP formulation and the primer regions of the ampliﬁed
material serve as controls to assess other sources of
mutation and potential sequencing errors.
Frequency and distribution of mutations
For each of the four dNTP formulations, 1 million arbi-
trarily chosen sequence reads were analyzed using CLC
Genomics Workbench. The raw base calls and associated
quality scores were exported from the Illumina platform
without applying ﬁlters. Then the sequences were trimmed
to remove adapter sequences and ambiguously read nu-
cleotides. Phi X 174 genomic DNA was sequenced in
parallel to provide calibration standards. Because there
was no ambiguity in aligning the individual reads
relative to the 169-nt reference sequence, the alignment
parameters were made highly permissive, requiring only
80% identity across 50% of the read length.
Mutations relative to the reference sequence were
evaluated by applying variable quality score standards,
thus providing an analysis of the trade-off between inclu-
siveness of potentially meaningful data and rejection of
potential sequencing errors. The quality score is a
measure of the conﬁdence of individual base calls,
derived from the relative signal intensity for each of the
four possible bases at that position (7,8). Quality scores
reﬂect the likelihood that a base is erroneously called, and
are calibrated according to how well they predict the
known sequence of a reference sample (in this case phi
X 174 DNA). Various quality score cut-offs were
applied to each nucleotide position and to the 5nt on
either side of that position. The quality scores ranged
from 0.06 to 100% tolerable error for the central nucleo-
tide, and from 0.16 to 100% tolerable error for the sur-
rounding nucleotides. The overall mutation rate did not
differ substantially for each of the four different dNTP
formulations over a range of quality scores of 0.06–
10%, but rose substantially when the tolerable error was
100% (Figure 2). This broad insensitivity of the observed
mutation rate to quality score cut-off suggests that the
observed rate reﬂects the true frequency of mutation.
The most conservative error threshold of 0.06% was
adopted for subsequent data analysis to minimize the in-
clusion of sequencing errors. Even after applying this con-
servative ﬁlter, there were an average of >40 000 reads per
nucleotide position. The coverage at each position is
shown in Supplementary Figure S1.
The overall mutation frequency with the standard
dNTPs was 0.08% per nucleotide position. In the
presence of 8-oxo-dGTP this increased to 0.39%, with
dPTP it was 0.91% and with combined 8-oxo-dGTP/
dPTP it was 1.03% (Table 1). Nearly all of the mutations
with 8-oxo-dGTP were A-to-C changes (referring to the
starting compared to product RNA), and these occurred
at a frequency of 1.20% per eligible position. An ‘eligible
position’ refers to A residues in the RNA for 8-oxo-dGTP
mutagenesis and to either A or G residues in the RNA for
dPTP mutagenesis. With dPTP, both A-to-G and G-to-A
changes were observed, at a frequency of 1.71 and 1.61%
per eligible position, respectively. With the combination of
8-oxo-dGTP and dPTP, A-to-C, A-to-G and G-to-A
changes all were observed, at a frequency of 1.09, 1.31
and 1.40%, respectively.
It is notable that 8-oxo-dGTP had an asymmetric effect,
generating frequent A-to-C changes, but C-to-A changes
at a rate than did not differ signiﬁcantly compared to the
control reaction with standard dNTPs. This indicates that
8-oxo-dGTP is readily incorporated opposite A residues
of an RNA template, but either 8-oxo-dGTP is not
incorporated opposite C residues or ATP is not readily
incorporated opposite 8-oxo-dG residues of a DNA
template. In contrast, there was no pronounced asym-
metry with dPTP, indicating that it can be incorporated
opposite A or G residues of an RNA template and that
GTP or ATP can be incorporated opposite dP residues of
8098 Nucleic Acids Research, 2010,Vol.38, No. 22a DNA template. The combination of 8-oxo-dGTP and
dPTP showed roughly additive effects compared to the
behavior of the two dNTP analogs alone.
With deep sequencing coverage, it was possible to de-
termine the mutation frequency at each nucleotide
position for each of the four dNTP formulations. Nearly
all of the eligible positions exhibited substantially higher
frequency of mutation compared to the non-eligible pos-
itions (Figure 3). There was a surprisingly high degree of
variation in mutation frequency at the different eligible
positions, with a SD close to the mean (Table 1). For
A-to-C changes brought about by 8-oxo-dGTP, the
range of mutation frequencies (at 31 eligible positions)
was 0.05–3.89%, with an interquartile range of
0.58–1.46%. For A-to-G changes brought about dPTP,
the range of mutation frequencies (at the same 31 pos-
itions) was 0.52–4.02%, with an interquartile range of
1.16–2.11%. For G-to-A changes brought about dPTP,
the range of mutation frequencies (at 33 eligible positions)
was 0.38–4.16%, with an interquartile range of
0.96–2.27%. The combination of 8-oxo-dGTP and dPTP
resulted in a distribution of mutations that was very
similar to the combined effects of 8-oxo-dGTP and
dPTP alone (Figure 4). This demonstrates the independent
and additive behavior of the two mutagens, as well as the
consistency of the observed position-dependent variation
among the different sample preparations.
Sources of position-speciﬁc variation
An analysis was performed to determine whether the fre-
quency of mutation at a particular position is inﬂuenced
by the identity of the immediately surrounding nucleo-
tides. For mutations at A positions brought about by
8-oxo-dGTP, there was a signiﬁcantly enhanced likelihood
of either C or U at the upstream (to the 50-side) nucleotide
position of the RNA, and conversely a signiﬁcantly
reduced likelihood of either C or U at the downstream
nucleotide position (Figure 5). For mutations at A pos-
itions brought about by dPTP, there was no effect of the
upstream nucleotide of the RNA, but a signiﬁcantly
enhanced likelihood of C at the downstream position.
For mutations at G positions brought about by dPTP,
there was both a reduced likelihood of U at the
upstream position and a reduced likelihood of A at the
downstream position.
Mutations induced by 8-oxo-dGTP are almost exclu-
sively due to its incorporation opposite A residues of the
RNA template. This requires 8-oxo-dGTP to adopt the
syn conformation (11), which appears to occur more
readily if the preceding residue of the cDNA is a pyrimi-
dine. Perhaps the reduced stacking energy of a preceding
pyrimidine is more conducive to the distorted geometry of
syn-8-oxo-dG. Once 8-oxo-dG has become incorporated,
there is a preference for a purine residue at the subsequent
position of the cDNA, perhaps as a means to overcome
the distorted geometry through increased stacking energy
of the trailing nucleotide.
P pairs ambiguously with either G or A, existing as
either the amino or imino tautomer, respectively (12,13).
A-to-G changes brought about by dPTP require
Figure 2. Effect of quality score on DNA sequence analysis.
(A) Average mutation frequency and (B) average coverage for different
quality score cut-offs. Error probabilities of 0.06, 0.32, 3.2, 10, 32 and
100% correspond to Phred quality scores for the sequenced nucleotide
of 32, 25, 15, 10, 5 and 0, respectively. Quality scores for the ﬁve
nucleotides on either side of the sequenced nucleotide were 28, 20,
10, 5, 0 and 0, respectively. The Phred quality score is given by: Q
=
 10 log10(P), where P is the calculated probability that the base call
is incorrect (7). Open circles, standard dNTPs; triangles, 8-oxo-dGTP;
squares, dPTP; diamonds, combined 8-oxo-dGTP/dPTP. The trend
lines in A were similar in form, but with different absolute values,
for the individual nucleotide positions. Error bars in B correspond to
one standard deviation, shown only for the standard dNTPs, but of
similar magnitude for the other three formulations.
Table 1. Type and frequency of mutations for four different dNTP
formulations
dNTP formulation Reference
nucleotide
Mutation frequency (%)
AGCU
Standard A – 0.03 0.01 0.01
G 0.05 – 0.01 0.07
C 0.07 0.01 – 0.04
U 0.01 0.01 0.03 –
8-oxo-dGTP A – 0.04 1.20±1.00 0.01
G 0.05 – 0.01 0.08
C 0.08 0.01 – 0.06
U 0.01 0.01 0.02 –
dPTP A – 1.71±0.89 0.01 0.01
G 1.61±0.86 – 0.01 0.07
C 0.07 0.01 – 0.05
U 0.01 0.01 0.03 –
8-oxo-dGTP + dPTP A – 1.31±0.70 1.09±0.92 0.01
G 1.40±0.80 – 0.01 0.08
C 0.09 0.01 – 0.05
U 0.01 0.01 0.03 –
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residues of the RNA template. This appears to occur more
readily when the preceding residue of the cDNA is dG. P
residues within the cDNA must then (as the amino
tautomer) direct incorporation of GTP into the product
RNA, an event that does not appear to be inﬂuenced by
the identity of the preceding residue of the RNA.
Conversely, G-to-A changes brought about by dPTP
require incorporation of dPTP (as the amino tautomer)
opposite G residues of the RNA template, which occurs
most readily when the preceding residue of the cDNA is
not T. P residues within the cDNA must then (as
the imino tautomer) direct incorporation of ATP into
the product RNA, which occurs most readily when the
preceding residue of the RNA is not U.
Taken together, nearest-neighbor effects account for
only a small portion of the observed position-speciﬁc vari-
ation in mutation frequency. Another potential source of
variation is the structure of the RNA template, which
becomes unfolded during reverse transcription, but none-
theless can affect the propensity of the RNA to track
through the polymerase active site, and therefore affect
the kinetics of dNTP incorporation (14,15). The secondary
structure of the starting molecule has been well
characterized (9,16,17). No obvious correlation exists
between secondary structural features and the frequency
of mutation at nearby positions (Supplementary Figure
S2). It is possible that the secondary structure of the
cDNA has some inﬂuence, although that structure is not
known.
Figure 3. Mutation frequency at each nucleotide position for four different dNTP formulations. (A), standard dNTPs; (B), 8-oxo-dGTP; (C), dPTP;
(D), combined 8-oxo-dGTP/dPTP. Nucleotide positions refer to the starting RNA, with the two primer regions (nucleotides 1–26 and 153–169)
demarcated. Positions that were eligible for mutation are shown in color: A residues (red) were eligible for mutation by either 8-oxo-dGTP or dPTP;
G residues (blue) were eligible for mutation by dPTP only. Note that mutation frequency is shown on a log scale.
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of mutations excluded residues within the two primer
regions, which might be regarded as immutable. The
region of the cDNA primer was never exposed to muta-
genic dNTP analogs, and the region of the second primer,
although exposed to analogs during cDNA synthesis,
would have had any mutations negated during subsequent
PCR ampliﬁcation. However, apparent mutations can
occur within the primer regions due to sequence hetero-
geneity of the primers themselves, mutations that arise
during colony ampliﬁcation within the Illumina sequencer
(which employed outside primers) or sequencing errors.
The median frequency of mutation per position within
the two primer regions was 0.04%, but there were several
positions with a mutation frequency that was at least
2-fold higher (Figure 3). Each of these relative hotspots
exhibited a particular favored mutation, and the pattern
of favored mutations was the same for all four dNTP
formulations. One position in particular, T154 within
the region of the cDNA primer, had a frequency of
T-to-C changes of 1–2%. This was most likely due to
compositional heterogeneity of the synthetic DNA
primer itself, although nothing unusual was noted
during the corresponding steps of its synthesis. For
non-eligible positions between the two primer regions
Figure 5. Analysis of the effect of adjacent nucleotides on the mutation
frequency at each eligible position. (A), Mutations at A positions
brought about by 8-oxo-dGTP; (B), Mutations at A positions
brought about by dPTP; (C), Mutations at G positions brought
about by dPTP. Adjacent nucleotides are either immediately
upstream (50-neighbor) or immediately downstream (30-neighbor)
within the starting RNA. Error bars correspond to 1 SD.
Figure 4. Comparison of mutation frequency at each eligible position
when exposed to either one or both mutagenic dNTP analogs.
(A), A-to-C mutations when exposed to either 8-oxo-dGTP or both
mutagens; (B), A-to-G mutations when exposed to either dPTP or
both mutagens; (C), G-to-A mutations when exposed to either dPTP
or both mutagens. Linear regression coefﬁcients were 0.97, 0.94 and
0.98, respectively.
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that for the two primer regions. This indicates that there is
a lower bound for the detection of true mutations of
 0.04–0.06%, which is determined by both false muta-
tions that arise during colony ampliﬁcation and
sequencing errors.
DISCUSSION
Recent advances in DNA sequencing technology make it
possible to determine the position-speciﬁc frequency of
mutation resulting from exposure to a mutagen, and to
obtain this information directly, without resorting to
phenotypic assays. In the present study, two mutagenic
dNTP analogs were examined, one a common cellular
mutagen and the other a synthetic compound used in lab-
oratory mutagenesis procedures. A particular set of
reaction conditions were chosen to maximize incorpor-
ation of the dNTP analogs during a single pass of an
RNA-dependent DNA polymerase. Other mutagens,
reaction conditions and polymerization protocols might
have been chosen and analyzed in a similar manner, but
the goal here was to achieve a high level of mutagenesis
to enable statistical analysis of the distribution of muta-
tions, while minimizing selective bias due to differential
ampliﬁcation.
As expected, 8-oxo-dGTP resulted in a substantially
increased frequency of transversion mutations due to its
ambiguous pairing with either C or A residues in the
starting RNA template (Figure 1A). These mutations
were asymmetrical, with A-to-C changes occurring at a
frequency of 1.2% per eligible position, but C-to-A
changes occurring at a frequency similar to that of the
control reaction with standard dNTPs. Human mitochon-
drial DNA polymerase has been shown to incorporate
8-oxo-dGTP 13-fold more readily opposite dA compared
to dC residues, and to incorporate dGTP 10
4-fold more
readily than 8-oxo-dGTP opposite dC residues (18). Thus,
even with the 160-fold concentration advantage of
8-oxo-dGTP relative to dGTP employed in the mutagen-
esis procedure, the incorporation of 8-oxo-dGTP likely
was disfavored at C positions. The recently reported
crystal structure of 8-oxo-dGTP bound opposite dA in
the active site DNA polymerase b conﬁrms the substan-
tially more favorable geometry of this pairing compared to
that of 8-oxo-dGTP and dC (19). dPTP, in contrast, gave
rise to A-to-G and G-to-A transition mutations in a sym-
metrical manner, occurring at a frequency of 1.7 and
1.6%, respectively. P is more ambiguous in its pairing
compared to 8-oxo-G because P can adopt either the
amino or imino tautomer (Figure 1B) in roughly equal
proportions (13).
The most striking ﬁnding of this study was the high
degree of position-speciﬁc variation in mutation fre-
quency. With the standard dNTPs the mean mutation fre-
quency was 0.08% per nucleotide position, with a SD of
0.06%. In the presence of one or both mutagenic dNTP
analogs the mutation frequency was substantially elevated
at all eligible positions, also with a SD close to the mean
(Table 1). The mutation frequency at each of the
non-eligible positions was highly consistent across the
four different dNTP formulations (Figure 3), as was the
mutation frequency at each of the eligible positions for
formulations involving either one or both mutagens
(Figure 4). Thus each nucleotide position appears to
have a distinct ‘personality’, with characteristic features
that are elicited by exposure to particular mutagens.
A previous study of 8-oxo-dGTP mutagenesis, employ-
ing either an RNA or DNA template and HIV-1 reverse
transcriptase, demonstrated 10-fold variation in the fre-
quency of A-to-C mutations at 20 eligible positions (3).
That study used a lacZ a-complementation assay to score
mutants based on phenotype, followed by conventional
sequence analysis to conﬁrm the indicated mutations.
Only  200 mutations were scored, compared to more
than 100 000 in the present study, but even at that lower
level of resolution the distribution of mutations appeared
to be highly non-uniform.
With the ﬁne-grained analysis enabled by deep
sequencing technology, it becomes clear that ‘random mu-
tagenesis’ is a misnomer. One can speak of protocols that
are intended to introduce mutations in an unpredictable
manner (20), and for a given nucleotide position the inci-
dence of mutation is likely to be probabilistic for individ-
ual molecules. However, haplotypes that involve
combinations of low-frequency mutations will be nearly
inaccessible in the population, unless the individual muta-
tions each confer selective advantage and can accumulate
successively. Conversely, combinations of high-frequency
mutations will be especially well represented, thus
allowing high-frequency mutations that are phenotypical-
ly neutral to be swept along with adaptive mutations
during selective enrichment.
One source of position-speciﬁc variation in mutation
frequency is the identity of the immediately adjacent nu-
cleotides, most apparent for mutations induced by
8-oxo-dGTP (Figure 5). Mutagenesis by 8-oxo-dGTP
depends on G assuming the syn conformation, and it is
not surprising that this can be inﬂuenced by both the
upstream nucleotide (for incorporating 8-oxo-G opposite
A) and downstream nucleotide (for extending the G-A
mismatch). However, the main sources of position-speciﬁc
variation remain obscure. The secondary structure of
the starting RNA template does not appear to play an
important role (Supplementary Figure S2). Rather,
position-speciﬁc variation likely reﬂects differential rates
of dNTP incorporation and subsequent extension that
occur in different sequence contexts (14,15). One could
investigate this possibility systematically by constructing
a family of templates containing, say, all 4096 possible
hexameric sequences, exposing them to a mutagen, and
using deep sequencing to provide a comprehensive assess-
ment of local sequence effects. Ideally these data should be
correlated with stepwise measurements of the rates of
reverse and forward transcription, obtained at single-
nucleotide resolution (21,22).
The picture that emerges is of a genotype that itself has
considerable phenotype. More properly, genotype should
be regarded as a purely informational entity that acquires
phenotypic characteristics only when embodied as a
physical molecule. The exploration of sequence space is
8102 Nucleic Acids Research, 2010,Vol.38, No. 22broadest when the opportunity for mutagenesis does not
vary for different sequences. Clearly this is not the case for
nucleic acid molecules that are copied by a polymerase.
Yet sequence space is so vast that even a 10-fold variation
in mutation frequency at different nucleotide positions
leaves ample opportunity to discover novel sequence com-
binations that enable evolutionary adaptation. As DNA
sequencing technology continues to advance and more
genomes are sequenced, it will be interesting to see the
extent to which the inherent chemical phenotype of the
genetic material can be discerned within biological organ-
isms. In some instances, mutational hotspots themselves
may be selectable features that promote the evolvability of
adaptive traits.
Laboratory mutagenesis procedures, such as those
described here, have practical applications in directed evo-
lution studies. Currently the most popular method for
‘random’ mutagenesis is error-prone PCR (23–26). The
use of 8-oxo-dGTP and/or dPTP provides an attractive
alternative (6), especially now that single-pass mutation
frequencies of 1–2% can be achieved. However, the result-
ing mutations are limited to only three types: A-to-C,
A-to-G and G-to-A changes (referring to the starting
compared to product RNA). If one applied the same tech-
nique to an antisense RNA template, generated
double-stranded DNA, and transcribed sense-strand
RNA products, then those products would contain, in
effect, U-to-G, U-to-C and C-to-U changes. If the asym-
metry of 8-oxo-dGTP mutagenesis could be overcome, for
example, by employing a different polymerase, then
C-to-A and G-to-U changes would be accessible as well.
Taken together, these procedures might be used to
generate 8 of the 12 types of single-nucleotide
substitutions.
The continuous in vitro evolution system, which has
been used to evolve ligase ribozymes (10,16), will beneﬁt
especially from having a means to introduce mutations at
high frequency and in a continuous manner. Thus far, the
selective power of this system has exceeded its ability to
generate novel variation, narrowing the breadth of the
evolutionary search. With a high level of mutagenesis, ap-
proaching the error threshold for the retention of genetic
information (27), it should be possible to explore sequence
space more broadly, even with the restrictions due to the
limited types of mutations and position-speciﬁc variation
in mutation frequency.
Deep sequencing analysis could be applied more
broadly to investigate the mutation spectrum of various
polymerases under various reaction conditions, including
following exposure of nucleic acid templates or dNTPs to
potential mutagens, during polymerization in the presence
of dNTP analogs or other mutagens, or following process-
ing of mutated nucleic acids by various DNA repair
enzymes. Until recently, it was necessary to carry out
phenotypic assays to score a sufﬁcient number of muta-
tions to provide statistically signiﬁcant information.
Next-generation sequencing technology now allows that
information to be obtained directly by performing
millions of individual sequence reads. A present limitation
is that the sample nucleic acid must be ampliﬁed prior to
sequencing, which can introduce false mutations and sets a
lower bound of  0.05% for the detection of true muta-
tions. With the advent of ‘third generation’ sequencing
technologies, especially those that allow direct and
repeated sequencing of individual nucleic acid molecules
(28), the threshold for detection of mutations will be sub-
stantially lower. Such methods will provide an even better
opportunity to uncover the inherent phenotypic properties
of individual DNA molecules.
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